Clinical trials / NCT05774756
NCT05774756Phase 3Active not recruiting

A Trial of Setmelanotide in Acquired Hypothalamic Obesity

Study sponsor: Rhythm Pharmaceuticals, Inc. · RYTM

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov recordCSV export · Pro
Primary completion2025-03-18Actual
Enrollment · participants143Actual
Source updated2026-08-10Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 3 fields changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Compare wording
− Before

Measure: Mean % change in BMI

+ After

Measure: Pivotal Cohort: Mean Percent Change From Baseline in Body Mass Index (BMI) After 52 Weeks on a Therapeutic Regimen

Participant count type changed

− Before

Estimated

+ After

Actual

Enrollment · participant count changed

− Before

120 participants (planned)

+ After

143 participants (actual)

Check registry source